Skip to Content

A262 15 mg A262 15 mg (Lansoprazole Delayed-Release 15 mg)

Pill with imprint A262 15 mg A262 15 mg is Green & White, Capsule-shape and has been identified as Lansoprazole Delayed-Release 15 mg. It is supplied by Xiromed LLC.

Lansoprazole is used in the treatment of barrett's esophagus; duodenal ulcer; duodenal ulcer prophylaxis; gerd; erosive esophagitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A262 15 mg A262 15 mg

Lansoprazole Delayed-Release

Imprint
A262 15 mg A262 15 mg
Strength
15 mg
Color
Green & White
Size
16.00 mm
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Xiromed LLC
National Drug Code (NDC)
70700-0262
Inactive Ingredients
methacrylic acid - ethyl acrylate copolymer (1:1) type a, hypromelloses, magnesium carbonate, mannitol, polysorbate 20, polyethylene glycol, sodium lauryl sulfate, sodium starch glycolate type A potato, sucrose, magnesium silicate, titanium dioxide, FD&C Blue No. 2, gelatin, ferric oxide yellow, ferrosoferric oxide, propylene glycol, butyl alcohol, isopropyl alcohol, shellac

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.